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Abstract
The contemporary scientific establishment equates hypothesis testing to good science. This stance
bypasses the preliminary need to identify a worthwhile hypothesis through rigorous observation of
natural processes. If alleviation of human suffering is claimed as the goal of a scientific undertaking,
it would be unfair to test a hypothesis whose relevance to human disease has not been satisfactorily
proven. Here, we argue that descriptive investigations based on direct human observation should
be highly valued and regarded essential for the selection of worthwhile hypotheses while the
pursuit of costly scientific investigations without such evidence is a desecration of the cause upon
which biomedical research is grounded.
There are good things so in the tide pools and interesting thoughts to be generated from the seeing. Every
new eye applied to the peephole which looks out at the world may fish in some new beauty and some new
pattern, and the world of the human mind must be enriched by such fishing.
John Steinbeck – Foreword to the Third Edition of Ed Ricketts' "Tides".
Descriptive studies will increase the efficiency of 
translational research
It is surprising how often a manuscript is dismissed by
reviewers as "just descriptive", regardless of the novelty of
the reported observation. On the other hand, we have not
once received a negative comment on a "mechanistic"
study, even if it lacks proof of the validity of the experi-
mental model and its relevance to human disease. Such
studies are automatically given the benefit of the doubt
based on predictable rationalizations vaguely offered in
the introductory paragraphs. As a consequence, innumer-
able conflicting results are published, each one a reflec-
tion of its own experimental bias. For example, in animal
models, Interleukin-23 can either promote or hamper
cancer growth [1-6]; yet, information about its bio-availa-
bility in human cancers and its modality of expression,
information that can potentially provide insight into the
interpretation of such models, is limited. As previously
argued [7-13], translational research is a two way road
with much to be learned from the unbiased study of
human beings and if a claim of relevance to human suffer-
ing is placed, compelling evidence should be provided.
Should studies that claim mechanistic explanations of
human pathology be required to provide descriptive evi-
dence of their applicability to humans? Should such evi-
dence be considered the horse pulling the cart, or can the
cart sometimes lead the horse? When is it appropriate to
search for mechanistic explanations and apply hypothesis
testing to the study of human disease? If one were to ser-
endipitously discover a drug that cures 100% of human
cancers, would we disregard it because we do not know its
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mechanism of action? Would indeed the mechanism mat-
ter? Shouldn't scientists focus on other medical problems
if truly interested in human welfare? Obviously, luck
alone is not likely to lead to big breakthroughs and the
chance of identifying a successful drug would be slim
using a random approach. A more reasonable strategy
requires the formulation of hypotheses based on available
knowledge. The problem occurs when the hypothesis
causes the investigator to drift away from human observa-
tion. When an investigator allows the hypothesis to
restrain his or her power of observation, hypothesis-
driven research can yield surprising conclusions. For
example, at a recent conference on melanoma, five speak-
ers presented back-to-back talks in which each provided
convincing evidence that her or his protein was "the
orchestrator" of melanoma metastases and, therefore, the
preferred target of future therapies. Nobody in the audi-
ence, taken by the elegance of the presentations, noted the
contradiction in these serial claims of five different
sources, each exclusively providing a mechanistic explana-
tion for the same phenomenon. Strikingly, descriptive
confirmation about the actual expression of these proteins
in human melanoma was neither provided nor requested.
Why should we risk tarnishing the beauty of our theories
with facts?
Basing hypotheses on preliminary experimental observa-
tion is dictated by the scientific method to which most of
us subscribe. Sir Francis Bacon would agree that the qual-
ity of a hypothesis depends on the quality and relevance
of the facts upon which it is based. The Scientific Revolu-
tion has been driven by induction that draws knowledge
from the natural world through experimentation, obser-
vation, and testing of hypotheses. It is true that facts can
only be confirmed by experimentation that is reproduci-
ble and testable; to achieve this goal, experiments are con-
trolled, ideally, by testing one variable at the time.
However, hypothesis testing is not meant to validate the
foundation upon which the hypothesis itself is based.
Instead, experimentation and observation should lead to
an accurate description of the facts upon which we could
base a relevant hypothesis. Kepler's description of the laws
of planetarian motion came much before a mechanistic
explanation could be offered by Newton's theory of uni-
versal gravitation. Kepler interpreted his findings through
a mixture of scientific and religious arguments. However,
his accurate and predictive descriptions provided the
coordinates for the formulation of Newton's theory.
Should Kepler's work have been dismissed as simply
descriptive?
Two botanists heard that in a village in the Country grew Blue
Chrysanthemums. For a whole summer they tried hard to find
them and as they were to give up they saw a girl, Klara, the vil-
lage simpleton, carrying bouquets of Blue Chrysanthemums.
On the day after, they followed the girl and saw a blue patch in
a meadow they had not previously violated because of a posted
"No Trespassing" sign. But the girl who could not read happily
wandered into the field and found the Blue Chrysanthemums.
Karel Capek – Short Novels
An observational approach is important also because it is
unbiased. Sometimes, a simple solution is missed because
we fail to observe the surrounding world with an open eye
as pre-conceived ideas may stir our thinking away from
novel pastures. Disrespect for observation is a recurring
theme in history. Don Quixotes thrived for centuries chas-
ing spectacular windmills and ignoring those Sancho Pan-
chas who may confuse them with facts. In post-
revolutionary France, the empirical method was born of
the desire to upset institutional privileges, and with this
fervor the modern discipline of surgery gained momen-
tum. At the time, surgery wedded the medical discipline to
the human body, violating the traditional teaching of
medicine in Latin, in which philosophy and religion were
dominant to the natural observation of cadaver dissection
or patient examination. Observation was considered vul-
gar and irrelevant and logical thinking de rigueur. William
Harvey's discovery that blood circulates was dismissed,
and those who advocated and practiced direct human
observation were not allowed to hold positions as profes-
sors, but could only be appointed as "demonstrators". It
took a century for visual analysis to take over theoretical
assumptions and for anatomy atlases to ratify the basis of
human physiology [14].
Where are we now?
Perhaps we should think in terms of theories and hypoth-
eses only being useful when the potential for observation
alone has been exhausted. Direct observation and discov-
ery-driven approaches should be sought first. With the
advent of modern high-throughput tools, existing theo-
ries based on oligo-thematic observations might be
shaken. For example, global transcript analysis of
melanoma metastases demonstrates that the administra-
tion of high dose interleukin-2 to cancer patients does not
induce migration of T cells within the tumor microenvi-
ronment [15] as previously hypothesized to explain the
observation that their disappearance from the circulation
was associated with increased frequency of tumor regres-
sion [16]. In contrast, an unbiased discovery-driven
approach demonstrated that interleukin-2 activates innate
immune mechanisms that had not been suspected before
and could not have been hypothesized based on available
knowledge. This unprecedented opportunity to reevaluate
the basis of human disease through high-throughput
observation cannot be dismissed.Journal of Translational Medicine 2007, 5:21 http://www.translational-medicine.com/content/5/1/21
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Yet, research funding practice strongly favors "hypothesis-
driven" proposals, disregarding the biases that the mini-
mization of experimental variability might introduce.
Hypothesis testing is the conclusive step that validates a
scientific observation but it does not support its relevance
claim. Whether a hypothesis is relevant to a particular
endeavor or not can only be tested within the studied
entity; it cannot be extrapolated through artificial experi-
mental models. Hypothesis testing aims to validate the
reproducibility and specificity of observations that may
explain a phenomenon. This approach is not necessarily
efficient, and hypotheses may often be wrong or irrelevant
if insufficient care is taken to collect facts to support it. In
times of abundance, efficiency may not be the highest pri-
ority, and scientists might have the chance to indulge the
luxury of speculative adventures in the world of the
unknown. But in these times of restricted funding oppor-
tunity, it behooves us to select our scientific challenges
parsimoniously by constantly confronting our intuitions
with the reality of human pathology. Consider this theo-
retical example: two scientists want to identify the cause of
a recurring noise on the other side of the wall. The first
provides reasonable hypotheses and proposes an elabo-
rate experimental model to reproduce the sound, imply-
ing a mechanistic relationship between the experimental
and actual phenomena. Such a proposal would be highly
praised by her/his peers because of the ingenuity of the
doctrine applied for the solution of a formidable chal-
lenge. The second scientist proposes to buy the key that
opens the door across the wall and look for what causes
the noise. The latter would be considered demeaning to
the scientific enterprise; over simplistic, unsophisticated,
discovery-driven, lacking a true hypothesis and would
therefore not be funded. But, in case common sense ought
to apply to scientific thinking, we should turn this reality
on its head, and demand that no grants be funded without
supportive evidence that prior observational tools have
been exhausted and the existence of a key and a door has
been sufficiently sought and excluded. Similar require-
ments could be applied for the retrospective judgment of
mechanistic, hypothesis-driven studies submitted for
publication.
The Journal of Translational Medicine welcomes the submis-
sion of high quality, purely descriptive studies that pro-
vide novel information relevant to human disease.
Mechanistic studies are also welcome. We hope that this
assortment may facilitate a shift of scientific investigation
toward human relevance. The discovery-driven approach
is often derided as a "fishing expedition". This unwar-
ranted lack of respect for piscatorial challenges inspires us
to refer cynics to Steinbeck's "On Fishing", where the vir-
tues of this ancient and noble art and its value in different
cultures are eloquently defended [17]. To the fishermen,
we wish good luck and eagerly await publication of their
next big catch in the Journal of Translational Medicine.
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